SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending amidst an "unprecedented" memory shortage, fueled by surging AI demand for High-Bandwidth Memory (HBM) that experts project will persist into 2027. The community is highly optimistic, highlighting Micron's unique position as the sole U.S. HBM producer, its relatively low valuation, and recent analyst upgrades. This strong bullish sentiment is reinforced by news of significant manufacturing expansions and a substantial insider share purchase.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is actively trending due to reports of China blocking shipments of its H200 AI chips, coupled with broader market uncertainty from escalating international trade tensions. While some investors anticipate market turbulence, a strong bullish contingent emphasizes NVIDIA's entrenched AI leadership and robust demand for its next-generation Blackwell and Rubin platforms, viewing current dips as prime buying opportunities.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is actively trending amid intense community debate surrounding its tokenomics and upcoming developments. While some express concern over perceived continuous coin minting impacting supply, others are highly optimistic about the proposed 'Mission 70' initiative, designed to significantly reduce inflation. This comes as the community anticipates key Web3 events, positioning ICP as a foundational layer for decentralized cloud and AI applications, with many expecting significant adoption news.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending due to Madryn Asset Management acquiring an unprecedented 91% stake, significantly restricting the public float. This has ignited fervent speculation among bulls, who anticipate a massive short squeeze similar to past events like HKD, projecting substantial price appreciation with many proclaiming "no top." However, there's also caution about potential delisting or restructuring by the majority owner to reduce costs, prompting debate about the stock's long-term trajectory and the risk for remaining shareholders.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is currently trending due to a sharp price drop and heightened volatility, fueled by recent critical reports and ongoing speculation of market manipulation. Despite the downturn, community discussions highlight conviction in its robust AI-powered ad platform and anticipate a rebound, particularly with upcoming earnings expected to showcase strong fundamentals.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a top trending stock as investors eagerly await its upcoming earnings report, with community perspectives sharply divided on whether the company will deliver a strong rebound from oversold conditions. A significant talking point revolves around the ongoing Warner Bros. Discovery acquisition saga, with bulls seeing it as a growth catalyst and bears concerned about its financial impact. Recent disclosures regarding bond purchases by a prominent political figure in both Netflix and Warner Bros. Discovery further add to the market's mixed sentiment and speculation surrounding the deal's future.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is actively discussed amidst renewed concerns over potential US tariffs on European economies related to Greenland, which has prompted caution in European markets and the bond sector. This geopolitical tension has sharply divided the community, with many anticipating a significant market pullback, while a strong counter-narrative expects a swift "buy the dip" recovery based on historical resilience to similar events.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following significant international developments, notably Saudi FDA approval for its Anktiva treatment in both bladder and lung cancer, signaling a global shift in cancer care. This news, amplified by recent public discussions from Dr. Patrick Soon-Shiong, is fueling widespread community excitement about a potential paradigm shift in oncology and intense speculation regarding a short squeeze amidst high market interest.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors anticipate an upcoming business update call, which follows a major joint venture with a Saudi industrial conglomerate securing 100% offtake for its Greenland rare earth production. The community is buzzing with discussion around Greenland's strategic importance for critical minerals, intensified by geopolitical developments highlighting the need for secure supply chains. This confluence of news positions CRML as a central focus for those seeking exposure to the crucial rare earths sector.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened market volatility driven by recent tariff threats from the former President regarding Greenland, sparking a heated debate about potential global trade friction. While many anticipate a market downturn, a notable segment of the community views this as a "buy the dip" opportunity, citing past market resilience to similar geopolitical developments. Investors are actively discussing the broader implications for tech and the market's direction ahead of key economic events and earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Week of AMLX March 20th Options Trading

Investors in Amylyx Pharmaceuticals Inc (Symbol: AMLX) saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.5% - What's Next?

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.5% - What's Next...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 7.2% - Time to Sell?

Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price Down 7.2% - Here's Why...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Rating of "Moderate Buy" by Analysts

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen ratings firms that are presently covering the company, Marketbeat...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Acquires $100,845.00 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) Director Karen Firestone purchased 8,100 shares of the company's stock in a transaction that occurred on Tuesday, December 23rd. The stock...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen cut Amylyx Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Saturday...

TFG Asset Management GP Ltd Makes New $1.40 Million Investment in Amylyx Pharmaceuticals, Inc. $AMLX

TFG Asset Management GP Ltd bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing...

683 Capital Management LLC Has $13.85 Million Stake in Amylyx Pharmaceuticals, Inc. $AMLX

683 Capital Management LLC lowered its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 10.4% during the second quarter, according to its most recent Form 13F filing...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen analysts that are currently covering the stock...

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced the presentation of early safety and tolerability data from its Phase 1 LUMINA trial of AMX0114 and results from...

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Current Price	$14.30
Prev Close	$13.52
Open	$13.56
Dividend Yield	N/A
50-Day Moving Average	$13.03
Beta	1.73
Avg. Volume	1.48M
PE Ratio	-7.95

52-Week High	$16.96
52-Week Low	$2.60
Market Capitalization	$1.57B
EPS (Annual)	-$4.43
Price to Book	4.73
Revenue Per Employee	$710,333.33
Enterprise Value/EBITDA	N/A

AMLX
Amylyx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMLX News

AMLXAmylyx Pharmaceuticals Inc